X4 Pharmaceuticals
XFOR • NASDAQ
X4 Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adam R. Craig, with a market cap of $367.3M.
CEOAdam R. Craig
Next Earnings
Upcoming earnings announcement for X4 Pharmaceuticals
Date
Thursday, April 30, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Revenue Estimate
$3.5M
Earnings History
Past 12 earnings reports for X4 Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.22Est: -$0.35 | +37.1% | $2.6MEst: $1.7M | +50.0% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.69Est: -$0.82 | +15.9% | $1.8MEst: $1.9M | -7.2% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$3.47Est: -$1.86 | -86.6% | $2.0MEst: $2.2M | -8.8% | 10-Q |
| May 1, 2025 | Q1 2025 | $0.04Est: -$3.75 | +101.1% | $28.8MEst: $7.0M | +309.7% | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.20Est: -$0.16 | -25.0% | $1.4MEst: $1.1M | +35.3% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.18Est: -$0.17 | -5.9% | $560.0K | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.07Est: $0.01 | -800.0% | $563.0KEst: $280.0K | +101.1% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.26Est: -$0.16 | -62.5% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.10Est: -$0.15 | +33.3% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.01Est: -$0.15 | +93.3% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.33Est: -$0.16 | -106.3% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.16Est: -$0.22 | +27.3% | - | — | — |